Fertility and Cardiovascular Risk in Men With Metabolic Syndrome

Last updated: November 3, 2021
Sponsor: University of Giessen
Overall Status: Active - Recruiting

Phase

N/A

Condition

Metabolic Syndrome

Diabetes Prevention

Metabolic Disorders

Treatment

N/A

Clinical Study ID

NCT03977064
EK205/16
  • Ages > 18
  • Male

Study Summary

Men diagnosed with metabolic syndrome (MetS) including obesity, hypertension, dyslipidemia and infertility will be assessed for cardiovascular and diabetes risk. The eligible patient will be randomised to one-year life-style intervention program including nutritional, behavioural and exercise counselling or standard care by the general physician. The aim of the program is to reduce cardiovascular and diabetes risks and hypogonadism as well.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age>18 years, wish for fatherhood in stable partnership, metabolic syndrome accordingto guidelines (minimum 3 out of 5 criteria), ready to participate in 1-yr lifestyleprogram

Exclusion

Exclusion Criteria:

  • Not conforming to MetS diagnosis criteria, sterilisation, promiscuous behaviour,contraindications against established medical or surgical treatment of obesity,participation in another weight-loss program

Study Design

Total Participants: 70
Study Start date:
January 01, 2021
Estimated Completion Date:
December 31, 2024

Connect with a study center

  • Justus Liebig University

    Gießen,
    Germany

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.